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Addiction is a chronic behavioral disorder characterized by compulsive drug seeking and increased propensity for relapse (Koob and Volkow, 2010) . Both internal (i.e., emotions and somatic states) and external (i.e., environmental cues and context) have been thoroughly implicated as underlying factors for not only facilitating drug-taking behavior, but also as driving forces in triggering drug relapse. Consequently, a highly complex network exists to integrate the relationship between environmental stimuli, genome remodeling, and behavioral output. Several lines of recent evidence have suggested that epigenetic regulation of gene expression parallels cocaine exposure and in turn mediates cocaine-induced behavioral adaptations.
Critical to this transcriptional regulation of gene expression is chromatin remodeling by covalent modification of histone proteins through chromatin-modifying enzymes, histone acetyltransferase (HAT) and histone deacetylase (HDAC). These proteins modify gene transcription by adding or removing acetyl groups to activate or silence gene transcription, respectively. HDAC proteins are divided into three distinct subclasses (l, lla/b, and IV), which target sequence-specific DNAbinding factors to regulate gene specificity. Notably, HDAC5, in addition to related class IIa/b HDACs, is regulated within neurons in an activity-dependent fashion while also possessing the unique ability to shuttle between the nucleus and cytoplasm (McKinsey et al., 2000) .
More recently, several important studies have implicated a previously unrecognized target, HDAC5, as a central regulator in the behavioral actions of cocaine. Renthal et al. (2007) pioneered the first study implicating HDAC5 in cocainemediated behavioral responses by reporting that chronic, not acute, cocaine exposure induced HDAC5 hyperphosphorylation-mediated nuclear export within the nucleus accumbens (NAc), a key brain region implicated in rewarding and reinforcing stimuli (Al-Hasani et al., 2015) . HDAC5 overexpression within the NAc decreased preference within a cocaine conditioned place paradigm (CPP), a Pavlovian, non-contingent model that measures the amount of time an animal spends in a chamber previously associated with a drug pairing. In line with this finding, HDAC5 knockout (KO) mice were found to have increased cocaine place preference after exposure to a chronic cocaine regimen. Based upon these studies, Renthal et al. (2007) concluded that repeated, chronic cocaine promotes pulsatile phosphorylation of HDAC5 nuclear exportation to allow for expression of cocaine-related genes. However, within HDAC5KO mice, HDAC5 is absent to control expression of these genes, thus allowing cocaine-related genes to accumulate over time and increase the sensitivity to cocaine reward. These novel findings were critical in identifying HDAC5 as a mediator of cocaine reward-related behavior; however, numerous questions arose following this study: in particular, how does cocaine mediate the downstream output of HDAC5 nuclear translocation?
In 2012, Taniguchi et al. (2012) set out to tackle the question of elucidating the mechanistic action of cocaine-induced HDAC5 nuclear localization. Nuclear translocation of HDAC5 occurs via dephosphorylation at three critical serine residues (S259, S279, and S498). Taniguchi et al. (2012) found that exposure to cocaine stimulates dephosphorylation of HDAC5 S279 via a cAMP-PP2A pathway to induce rapid and transient nuclear accumulation. In accordance with these findings, site-specific mutation of S279 to a glutamic acid (S279E), which mirrors the HDAC5 phosphorylated state, blocked HDAC5 nuclear accumulation. Additionally, mutation of S279 to an alanine (S279A), which mimics a nonphosphorylated HDAC5 state, did not affect HDAC5 translocation, suggesting that dephosphorylation of S259 and S498 is also needed for HDAC5 nuclear accumulation. To determine the functional role of HDAC5 phosphorylation in cocaine-mediated behaviors, Taniguchi et al. (2012) bilaterally delivered viral microinjections of HDAC5 wild-type (WT), mutants (S279A or S279E), or GFP (control) into the NAc of mice before the animals underwent cocaine CPP. Overexpression of S279A HDAC5 mutant significantly decreased the development, but not the expression, of a cocaine place preference. Extending the work of Renthal et al. (2007), Taniguchi et al. (2012) concluded that HDAC5 dephosphorylation at S279, via a cAMP-PP2A pathway, within the NAc is vital for suppressing cocaine preference behavior by acting as a brake to counteract cocaine-induced maladaptive neuroadaptations. However, these findings prompted several additional questions: what are the target genes regulated by HDAC5? How does HDAC5 control cocaine CPP? What is the role for HDAC5 and HDAC5-associated target genes in a contingent model of drug addiction?
In this issue of Neuron, Taniguchi et al. (2017) greatly expand on the HDAC5-cocaine relationship by investigating how HDAC5 mediates cocaine reward as well as elucidating the potential HDAC5 targets that regulate this effect. Utilizing viral-mediated gene transfer Taniguchi et al. (2017) employed in vitro and in vivo models to express full-length HDAC5 (WT), a dephosphorylated triple mutant (S259A/S279A/S498A or ''3SA''), EGFP (control), or a dephosphorylated HDAC5 mutant that lacks the ability to interact with MEF2 transcription factors (3SA-DMEF2). MEF2 are a group of transcription factor proteins known to interact with HDAC5. Both 3SA and 3SA-DMEF2 allowed for HDAC5 nuclear accumulation within striatal neuronal culture. In accordance with their hypothesis, HDAC5-3SA and 3SA-DMEF2 overexpression within the NAc suppressed cocaine CPP; however, there was no difference in cocaine preference behavior between HDAC5-3SA and 3SA-DMEF2, implying that dephosphorylation of HDAC5 can reduce cocaine preference independent of MEF2 interaction. To extend their findings to a more canonical drug addiction model, Taniguchi et al. (2017) took the laborious and challenging next step and tested whether HDAC5 WT or HDAC5-3SA NAc overexpression would influence volitional cocaine-taking and -seeking behaviors in a mouse intravenous cocaine self-administration paradigm. This rodent model replicates human drug-taking behavior and allows the rodent to determine the timing and amount of drug delivery through operant responding. Interestingly, bilateral NAc overexpression of HDAC5-3SA did not alter the cocaine dose-response relationship, cocaine-taking behavior on a fixed-ratio (FR) schedule, or a progressive ratio schedule of reinforcement. At face value, this seems to initially oppose the findings of the numerous cocaine CPP experiments (Renthal et al., 2007; Taniguchi et al., 2012) . It is plausible that nuclear HDAC5 fails to mediate cocaine-responding behavior in an operant paradigm as this paradigm represents goal-directed behavior, and the importance of the cue/ context to the behavioral paradigm (in comparison to the CPP paradigm) is less consequential to the cocaine-mediated behavior. However, upon closer inspection, Taniguchi et al. (2017) found that HDAC5-3SA mutants exhibited reductions in operant models of drug relapse, both in cue-induced reinstatement and cocaine prime-induced reinstatement. These findings expand greatly on the previous findings by providing a mechanistic behavioral framework for HDAC5's contribution to cocaine addiction-like phenotypes. Taniguchi et al. (2017) now propose that nuclear HDAC5 acts to reduce the external (cue light) and internal (priming with cocaine) cue-drug associations, an important advance that strongly implicates this molecular programing in the lasting changes induced by drugs of abuse, such as cocaine.
One prevailing question from the aforementioned studies is what are the potential downstream targets of HDAC5 in regulating cocaine-mediated behaviors. To identify HDAC5 genomic targets, Taniguchi et al. (2017) employed chromatin immunoprecipitation sequencing (ChIPseq) and found that HDAC5 associated with 1,000 genomic targets. Of particular appeal was neuronal PAS domain protein 4 (Npas4), a HDAC5 target that appeared absent in HDAC5KO mice, and showed the highest enrichment within the ChIP-seq assay. Activated by glutamatergic synaptic activity, Npas4 is an early-response transcription factor that represents a homeostatic switch regulating excitatory-inhibitory balance within neural circuits (Spiegel et al., 2014) . Remarkably, membrane depolarizationinduced transcription of Npas4 in cultured striatal neurons was absent in both the 3SA and 3SA-DMEF2 HDAC5 mutants. This loss of Npas4 expression was also present when 3SA was virally injected within the NAc, indicating that nuclear HDAC5 negatively regulates Npas4 expression. Further characterization of Npas4 gene expression revealed that cocaine induced rapid, transient increases in Npas4 and cFos co-expression predominantly within multiple GABAergic neuronal subtypes of the NAc.
Accompanying the findings that increased nuclear HDAC5 attenuates development of cocaine CPP, viral vector-mediated knockdown of Npas4 and conditional deletion of Npas4 in the NAc both produced a significant reduction in cocaine CPP behavior. These findings, combined with the previous experiments, suggest that Npas4 is required for development of cocaine reward-contextual associations, and this is mediated by the phosphorylation-dependent regulation of nuclear HDAC5. Taniguchi et al. (2017) next tested whether conditional deletion of Npas4 in the NAc mediates cocainetaking behavior and reinstatement of cocaine seeking. Contrasting the findings from HDAC5 manipulation, site-specific deletion of Npas4 did not alter cocainetaking behavior on a FR schedule or battery of reinstatement tests for cocaine seeking, although there was an interesting trend for decreased responding within cue-induced reinstatement. Taniguchi et al. (2017) suggest that additional or distinct HDAC5 gene targets (notably Slc1a2, GLT1; Gria1, GluA1; and Ptk2, FAK) may account for these findings. It should also be noted that cocaine induced cFos-positive cells within the NAc that were absent of Npas4, further suggesting that there are likely other cocaine-responsive gene targets, apart from Npas4, exerting their effects on cocaine-induced behavioral neuroadaptations. Npas4 has been shown to mediate homeostatic excitatory-inhibitory balance within neural circuits, as well as regulate the number of inhibitory synapses (Bloodgood et al., 2013) , so it's plausible that long-term knockdown of Npas4 within the NAc produces a dysfunctional NAc state that is not recapitulated when HDAC5-3SA is overexpressed in the NAc. Thus far, this research study supports the idea that dephosphorylated nuclear HDAC5 within the NAc regulates cocaine experiencedependent reward sensitivity, in part, through Npas4 gene regulation (see Figure 1 for summary). However, this leads to many unresolved questions with respect to fleshing out the role of HDAC5 in mediating addiction-relevant behaviors and identifying the role(s) of other HDAC5 target genes within cocaine addiction.
A general question is whether the findings surrounding the actions of HDAC5 extend to other drugs of abuse, in particular, other classes of psychostimulants, as there is evidence that NAc HDAC5 expression may be mediated by amphetamine exposure (Liu and Liu, 2016) . If this holds true, it will be critical to examine NAc nuclear HDAC5 in the context of non-drug reward-context associations. Previous studies have suggested that NAc HDAC5 does not directly impact natural reward behavior, as HDAC5KO mice (Renthal et al., 2007) and S279A mutants (Taniguchi et al., 2012) do not show differences within a sucrose preference assay that measures general sucrose intake. However, in light of the recent study, it may prove beneficial to examine the role of NAc HDAC5 in natural reward behavior dependent upon contextual and cue information, as well as testing these hypotheses for other widely abused drugs, like nicotine, opiates, and even other brain regions like the hippocampus, where drugcue associations are also thought to be encoded (Xia et al., 2017) .
Additionally, further examination of the role of HDAC5 in stress-induced maladaptive behaviors may prove beneficial with particular regard to stress-induced reinstatement. Taniguchi et al. (2017) observed no effect of NAc HDAC5-3SA on stress-induced reinstatement although they reported a high degree of variability that permitted the inability to draw any conclusive results. In fact, chronic stress has been shown to induce an upregulation of nuclear HDAC5, in addition to HDAC5KO mice exhibiting increased sensitivity to the effects of chronic stress (Renthal et al., 2007) . Therefore, HDAC5 likely contributes to stress-induced behavioral responses, but it is still unclear whether HDAC5 is capable of regulating stress-induced increases in drug-taking behavior or stress-induced reinstatement of drug seeking. Parsing out the role of these pathways in the stress response could provide a mechanism whereby HDAC5 regulates both the cue-drug interaction and the stress-drug interaction, a phenomenon that has proven difficult in the drug addiction field. Further comprehension of downstream HDAC5 targets in drug-mediated behaviors will be a daunting task but one that will prove critical to fully understanding how psychostimulants and other drugs of abuse impose long-lasting changes in reward systems and reinforcement circuits within an organism. This report offers exciting possibilities for our understanding of the long-lasting changes that drugs of abuse induce, but also holds promise in identifying new target substrates and downstream genes that may be potential therapeutic interventions.
